Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Change in Inventory: 2022-2025

Historic Change in Inventory for InMed Pharmaceuticals (INM) over the last 4 years, with Jun 2025 value amounting to -$283,151.

  • InMed Pharmaceuticals' Change in Inventory fell 190.16% to -$70,366 in Q3 2025 from the same period last year, while for Sep 2025 it was -$329,266, marking a year-over-year decrease of 209.81%. This contributed to the annual value of -$283,151 for FY2025, which is 327.59% down from last year.
  • InMed Pharmaceuticals' Change in Inventory amounted to -$283,151 in FY2025, which was down 327.59% from -$66,220 recorded in FY2024.
  • InMed Pharmaceuticals' 5-year Change in Inventory high stood at $2.0 million for FY2022, and its period low was -$565,561 during FY2023.
  • Its 3-year average for Change in Inventory is -$304,977, with a median of -$283,151 in 2025.
  • In the last 5 years, InMed Pharmaceuticals' Change in Inventory soared by 88.29% in 2024 and then slumped by 327.59% in 2025.
  • InMed Pharmaceuticals' Change in Inventory (Yearly) stood at $2.0 million in 2022, then plummeted by 128.23% to -$565,561 in 2023, then spiked by 88.29% to -$66,220 in 2024, then slumped by 327.59% to -$283,151 in 2025.